Literature DB >> 27885282

Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine.

Kathleen M Giacomini1,2, Sook Wah Yee1, Taisei Mushiroda3, Richard M Weinshilboum4, Mark J Ratain5, Michiaki Kubo3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27885282      PMCID： PMC5443656          DOI： 10.1038/nrd.2016.234

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  10 in total

1.  ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

Authors:  Jacques Fellay; Alexander J Thompson; Dongliang Ge; Curtis E Gumbs; Thomas J Urban; Kevin V Shianna; Latasha D Little; Ping Qiu; Arthur H Bertelsen; Mark Watson; Amelia Warner; Andrew J Muir; Clifford Brass; Janice Albrecht; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2010-02-21       Impact factor: 49.962

2.  Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing.

Authors:  S G Leckband; J R Kelsoe; H M Dunnenberger; A L George; E Tran; R Berger; D J Müller; M Whirl-Carrillo; K E Caudle; M Pirmohamed
Journal:  Clin Pharmacol Ther       Date:  2013-05-21       Impact factor: 6.875

3.  Massive schizophrenia genomics study offers new drug directions.

Authors:  Elie Dolgin
Journal:  Nat Rev Drug Discov       Date:  2014-08-18       Impact factor: 84.694

4.  A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.

Authors:  M Tohkin; N Kaniwa; Y Saito; E Sugiyama; K Kurose; J Nishikawa; R Hasegawa; M Aihara; K Matsunaga; M Abe; H Furuya; Y Takahashi; H Ikeda; M Muramatsu; M Ueta; C Sotozono; S Kinoshita; Z Ikezawa
Journal:  Pharmacogenomics J       Date:  2011-09-13       Impact factor: 3.550

Review 5.  Human leukocyte antigen-associated drug hypersensitivity.

Authors:  Patricia T Illing; Julian P Vivian; Anthony W Purcell; Jamie Rossjohn; James McCluskey
Journal:  Curr Opin Immunol       Date:  2012-11-08       Impact factor: 7.486

6.  Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α-based regimens.

Authors:  A J Muir; L Gong; S G Johnson; M T M Lee; M S Williams; T E Klein; K E Caudle; D R Nelson
Journal:  Clin Pharmacol Ther       Date:  2013-10-04       Impact factor: 6.875

7.  Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.

Authors:  Wen-Hung Chung; Wan-Chun Chang; Yun-Shien Lee; Ying-Ying Wu; Chih-Hsun Yang; Hsin-Chun Ho; Ming-Jing Chen; Jing-Yi Lin; Rosaline Chung-Yee Hui; Ji-Chen Ho; Wei-Ming Wu; Ting-Jui Chen; Tony Wu; Yih-Ru Wu; Mo-Song Hsih; Po-Hsun Tu; Chen-Nen Chang; Chien-Ning Hsu; Tsu-Lan Wu; Siew-Eng Choon; Chao-Kai Hsu; Der-Yuan Chen; Chin-San Liu; Ching-Yuang Lin; Nahoko Kaniwa; Yoshiro Saito; Yukitoshi Takahashi; Ryosuke Nakamura; Hiroaki Azukizawa; Yongyong Shi; Tzu-Hao Wang; Shiow-Shuh Chuang; Shih-Feng Tsai; Chee-Jen Chang; Yu-Sun Chang; Shuen-Iu Hung
Journal:  JAMA       Date:  2014-08-06       Impact factor: 56.272

8.  A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia.

Authors:  Suk-Kyun Yang; Myunghee Hong; Jiwon Baek; Hyunchul Choi; Wanting Zhao; Yusun Jung; Talin Haritunians; Byong Duk Ye; Kyung-Jo Kim; Sang Hyoung Park; Soo-Kyung Park; Dong-Hoon Yang; Marla Dubinsky; Inchul Lee; Dermot P B McGovern; Jianjun Liu; Kyuyoung Song
Journal:  Nat Genet       Date:  2014-08-10       Impact factor: 38.330

9.  Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.

Authors:  S A Scott; K Sangkuhl; C M Stein; J-S Hulot; J L Mega; D M Roden; T E Klein; M S Sabatine; J A Johnson; A R Shuldiner
Journal:  Clin Pharmacol Ther       Date:  2013-05-22       Impact factor: 6.875

10.  Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update.

Authors:  M A Martin; J M Hoffman; R R Freimuth; T E Klein; B J Dong; M Pirmohamed; J K Hicks; M R Wilkinson; D W Haas; D L Kroetz
Journal:  Clin Pharmacol Ther       Date:  2014-02-21       Impact factor: 6.875
  10 in total
  32 in total

1.  Host genetics and gut microbiota cooperatively contribute to azoxymethane-induced acute toxicity in Collaborative Cross mice.

Authors:  Chenhan Zhong; Li He; Sun-Young Lee; Hang Chang; Yuqing Zhang; David W Threadgill; Ying Yuan; Fuling Zhou; Susan E Celniker; Yankai Xia; Antoine M Snijders; Jian-Hua Mao
Journal:  Arch Toxicol       Date:  2021-01-17       Impact factor: 5.153

2.  The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development.

Authors:  Joshua C Denny; Sara L Van Driest; Wei-Qi Wei; Dan M Roden
Journal:  Clin Pharmacol Ther       Date:  2018-02-05       Impact factor: 6.875

Review 3.  Full genetic analysis for genome-wide association study of Fangji: a powerful approach for effectively dissecting the molecular architecture of personalized traditional Chinese medicine.

Authors:  Gang Chen; Wen-da Xue; Jun Zhu
Journal:  Acta Pharmacol Sin       Date:  2018-02-08       Impact factor: 6.150

4.  The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants.

Authors:  Ari Allyn-Feuer; Alex Ade; Jasmine A Luzum; Gerald A Higgins; Brian D Athey
Journal:  Pharmacogenomics       Date:  2018-02-05       Impact factor: 2.533

5.  Beyond drugs: the evolution of genes involved in human response to medications.

Authors:  Silvia Fuselli
Journal:  Proc Biol Sci       Date:  2019-10-23       Impact factor: 5.349

Review 6.  Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.

Authors:  Sook Wah Yee; Deanna J Brackman; Elizabeth A Ennis; Yuichi Sugiyama; Landry K Kamdem; Rebecca Blanchard; Aleksandra Galetin; Lei Zhang; Kathleen M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2018-05-31       Impact factor: 6.875

Review 7.  Personalized Medicine and the Power of Electronic Health Records.

Authors:  Noura S Abul-Husn; Eimear E Kenny
Journal:  Cell       Date:  2019-03-21       Impact factor: 41.582

8.  Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.

Authors:  Taisei Mushiroda; Yukitoshi Takahashi; Teiichi Onuma; Yoshiaki Yamamoto; Tetsumasa Kamei; Tohru Hoshida; Katsuya Takeuchi; Kotaro Otsuka; Mitsutoshi Okazaki; Masako Watanabe; Kosuke Kanemoto; Tomohiro Oshima; Atsushi Watanabe; Shiro Minami; Kayoko Saito; Hisashi Tanii; Yasushi Shimo; Minoru Hara; Shinji Saitoh; Toshihiko Kinoshita; Masaki Kato; Naoto Yamada; Naoki Akamatsu; Toshihiko Fukuchi; Shigenobu Ishida; Shingo Yasumoto; Atsushi Takahashi; Takeshi Ozeki; Takahisa Furuta; Yoshiro Saito; Nobuyuki Izumida; Yoko Kano; Tetsuo Shiohara; Michiaki Kubo
Journal:  JAMA Neurol       Date:  2018-07-01       Impact factor: 18.302

Review 9.  Biomarkers: Delivering on the expectation of molecularly driven, quantitative health.

Authors:  Jennifer L Wilson; Russ B Altman
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-03

Review 10.  Benefits and limitations of genome-wide association studies.

Authors:  Vivian Tam; Nikunj Patel; Michelle Turcotte; Yohan Bossé; Guillaume Paré; David Meyre
Journal:  Nat Rev Genet       Date:  2019-08       Impact factor: 53.242
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.